Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin

被引:84
作者
Evans, BAJ
Elford, C
Pexa, A
Francis, K
Hughes, AC
Deussen, A
Ham, J
机构
[1] Cardiff Univ, Ctr Endocrine & Diabet Sci, Cardiff CF14 4XN, Wales
[2] Cardiff Univ, Dept Child Hlth, Cardiff, Wales
[3] Carl Gustav Univ, Fac Med, Inst Physiol, Dresden, Germany
关键词
osteoprogenitor cells; adenosine; adenosine receptors; IL-6; osteoprotegerin;
D O I
10.1359/JBMR.051021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Maintaining skeletal homeostasis relies on there being a balance between bone formation and resorption; an imbalance between these processes can lead to diseases such as osteoporosis and rheumatoid arthritis. Recent reports showed that locally produced ATP, acting through P2 receptors, has pronounced effects on bone formation. However, ATP can be enzymatically cleaved to adenosine that has little or no activity at P2 receptors but mediates its action through the P1 family of receptors. We studied whether adenosine may also have an important role in controlling bone cell differentiation and function. Materials and Methods: Extracellular adenosine levels were analyzed by high-performance liquid chromatography in HCC1 and bone marrow stromal (BMS) cells. Ecto-5'-nucleotidase (CD73) expression and activity was determined by RT-PCR, immunocytochemistry, and the cleavage of etheno-AMP to ethenoadenosine. Adenosine receptor expression and activity were determined by RT-PCR and cAMP measurements. The effects of adenosine receptor agonists on IL-6, osteoprotegerin (OPG), and RANKL expression were determined by ELISA and QRT-PCR. Results: HCC1 and BMS cells produce adenosine and express CD73 and all four adenosine receptor subtypes. The A2b receptor was shown to be functionally dominant in HCC1 cells, as determined by cAMP production and in its stimulation of IL-6 secretion. Adenosine receptor agonism also inhibited OPG secretion and OPG but not RANKL mRNA expression. Conclusions: Our findings show that HCC1 and primary BMS cells produce adenosine, express CD73 and all four adenosine receptor subtypes. In HCC1 cells, adenosine has a potent stimulatory action on IL-6 secretion but an inhibitory action on OPG expression.. These data show for the first time that adenosine may be an important regulator of progenitor cell differentiation and hence an important local contributor to the regulation of bone formation and resorption.
引用
收藏
页码:228 / 236
页数:9
相关论文
共 47 条
[1]   PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS [J].
ABBRACCHIO, MP ;
BURNSTOCK, G .
PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) :445-475
[2]   THE EFFECTS OF PYROGLUTAMYLGLUTAMYLPROLINEAMIDE, A PEPTIDE RELATED TO THYROTROPIN-RELEASING-HORMONE, ON RAT ANTERIOR-PITUITARY-CELLS IN CULTURE [J].
ASHWORTH, RJ ;
HAM, J ;
COCKLE, SM .
JOURNAL OF ENDOCRINOLOGY, 1994, 142 (01) :111-118
[3]   Effects of adenosine on bacterial lipopolysaccharide- and interleukin 1-induced nitric oxide release from equine articular chondrocytes [J].
Benton, HP ;
MacDonald, MH ;
Tesch, AM .
AMERICAN JOURNAL OF VETERINARY RESEARCH, 2002, 63 (02) :204-210
[4]  
Boyle DL, 2001, J PHARMACOL EXP THER, V296, P495
[5]  
Buchholz J, 2004, J Orthop Surg (Hong Kong), V12, P205
[6]   Release and interconversion of P2 receptor agonists by human osteoblast-like cells [J].
Buckley, KA ;
Golding, SL ;
Rice, JM ;
Dillon, JP ;
Gallagher, JA .
FASEB JOURNAL, 2003, 17 (11) :1401-1410
[7]   Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-κB ligand [J].
Buckley, KA ;
Hipskind, RA ;
Gartland, A ;
Bowler, WB ;
Gallagher, JA .
BONE, 2002, 31 (05) :582-590
[8]  
Burnstock G., 1978, CELL MEMBRAIN RECEPT, P107, DOI DOI 10.1016/0014-5793(79)81367-8
[9]   Molecular action of methotrexate in inflammatory diseases [J].
Chan, ESL ;
Cronstein, BN .
ARTHRITIS RESEARCH, 2002, 4 (04) :266-273
[10]   Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor κB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells:: comparison of the effects of 17-β oestradiol and raloxifene [J].
Cheung, J ;
Mak, YT ;
Papaioannou, S ;
Evans, BAJ ;
Fogelman, I ;
Hampson, G .
JOURNAL OF ENDOCRINOLOGY, 2003, 177 (03) :423-433